短缺药品储备政策的实施现状与优化——以江苏省为例  

Implementation Status and Optimization of Shortage Drug Reserve Policy——A Case Study of Jiangsu Province

作　　者：俞心怡 吴培 胡楠清 李军[1] 茅宁莹[1] YU Xin-yi;WU Pei;HU Nan-qing;LI Jun;MAO Ning-ying(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing Jiangsu 211198,China;不详)

机构地区：[1]中国药科大学国际医药商学院,江苏南京211198

出　　处：《卫生经济研究》2021年第11期29-32,共4页

基　　金：国家社科基金重大项目“我国创新药物政策环境研究”(15ZDB167)子课题“我国药物政策环境构建及模拟运行”;产学研深度融合的江苏省生物医药技术创新体系建设研究(BR2020089);江苏省科技厅政策引导类计划(软科学研究)。

摘　　要：深入分析我国短缺药品储备政策的发展历程及现状,探究现阶段存在的不足,结合江苏省经验,提出进一步优化政策的建议:细化各部门职责,加强短缺药品信息沟通;适当延长承储企业更换调整的周期;科学优化储备品种结构,适度加大储备资金投入;政府-企业-公众协同,应对药品短缺问题。This paper makes an in-depth analysis of the development process and status of shortage drug reserve policy in China,analysis the shortcomings at the present stage,and put forward some suggestions for further optimizing the policy based on the experience of Jiangsu Province:refining the responsibilities of various departments and strengthening the communication of shortage drug information;appropriately prolonging the period of replacement and adjustment of storage enterprises;scientifically optimizing the variety structure of reserves and appropriately increasing the investment of reserve funds;by government-enterprise-public coordination to deal with the problem of drug shortage.

关 键 词：短缺药品 药品储备 承储企业 

分 类 号：R95[医药卫生—药学]